Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance
Philips Spectral CT 7500 RT Spectral CT 7500 RT clinical November 12, 2024 Designed specifically for use in radiation oncology,...
Healthcare
OneMedNet Announces Continued Investment into Bitcoin
MINNEAPOLIS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a pioneer in curating regulatory-grade...
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedRxiv and BioRxiv, Respectively
CANOPY manuscript preprint includes six-month off-drug follow-up period that highlighted strong protection by pemivibart versus placebo in the immunocompetent Cohort...
PPJ Healthcare Enterprises Expands Business with New Health & Wellness Franchises
TAMPA, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) announces today that the company...
Vosita Announces New Features and Exciting Giveaway
PARAMUS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vosita, an emerging leader in healthcare appointment scheduling, is proud to announce...
Vitalchat Strengthens Leadership Team
Jerry Carter and Mackenzie Laughridge Join to Drive Growth and Expand Virtual Nursing SolutionsASHBURN, VA / ACCESSWIRE / November 12,...
XiFin, Inc. Achieves Sixth Consecutive #1 Client Experience Rating in Laboratory and Ancillary Revenue Cycle Services, Black Book Survey
TAMPA, FL / ACCESSWIRE / November 12, 2024 / Black Book Research has announced the leading comprehensive revenue cycle management...
Moderna Tops BioSpace’s Best Places to Work Ranking for Fourth Consecutive Year
CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one...
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
Strengthened Cash, Strategic Refocus and Pipeline Progress Define Transformative Quarter€400 million upfront payment from restructured GSK collaboration reflected in financials,...
Noble Capital Markets Initiates Equity Research Coverage on Zomedica
ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care...
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues
Conference call will be held today, Tuesday, November 12 at 9:00 am ETCARMEL, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) --...
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents...
Nkarta to Participate in an Upcoming Investor Conference
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural...
Intercept Receives Complete Response Letter from FDA Addressing OCALIVA supplemental New Drug Application (sNDA)
MORRISTOWN, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today...
Araris Biotech Publishes Foundational Science Behind its Novel Antibody-Drug Conjugate Platform in ChemBioChem
First characterization of its novel conjugation technology for creating stable, well-defined ADCs with linkers that enable payload attachment to native,...
LENZ Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial...
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
GERMANTOWN, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on...
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
TORONTO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device...
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...
MintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural Implants
Latest capital raise will accelerate delivery of silicon roadmap to drive next-generation implantable devices for neurological applications LONDON, Nov. 12,...